Amsterdam Universitair Medisch Centrum

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Heart failure1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Amgen2 trials
• Nick Beije1 trial

Running trials

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Recruiting

  Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

  NCT07260435· Phase 3· Nick Beije· Source

  Contact: Prof. dr. A.J.M. van den Eertwegh

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Obesity1 recruiting
• Prostate cancer1 recruiting